Implementation of Computer-Based Quality-of-Life Monitoring in Brain Tumor Outpatients in Routine Clinical Practice

Journal of Pain and Symptom Management

Volumn 39, Issue 2, 2010, Pages 219-229

  Erharter, Astrid ^a   Giesinger, Johannes ^a   Kemmler, Georg ^a   Schauer Maurer, Gabriele ^a   Stockhammer, Guenter ^a   Muigg, Armin ^a   Hutterer, Markus ^a   Rumpold, Gerhard ^a   Sperner Unterweger, Barbara ^a   Holzner, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

assessment; Computer; monitoring; neuro oncology; quality of life

Indexed keywords

CYTARABINE; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN CANCER; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL PRACTICE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; OLIGODENDROGLIOMA; ONCOLOGY; OUTPATIENT; PATIENT MONITORING; PHYSICIAN; QUALITY CONTROL; QUALITY OF LIFE; SOCIAL PSYCHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMPUTERS, HANDHELD; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OUTPATIENTS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 75749130293     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.06.015     Document Type: Article

References (32)

1. National Cancer Institute. Surveillance epidemiology and end results (SEER) cancer statistics review, 1975-2005 (2008), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2005 Accessed October 17, 2008
2. Efficace F., and Bottomley A. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 38 (2002) 1824-1831
3. Hahn C., and Dunn R. Prospective study of neuropsychologic testing and quality of life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55 4 (2003) 992-999
4. Lahrmann H., Oberndorfer S., and Grisold W. Therapeutic concepts for primary malign tumors. Journal für Neurologie, Neurochirurgie und Psychiatrie 2 2 (2001) 16-20
5. Higginson I.J., and Carr A.J. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 322 7297 (2001) 1297-1300
6. Middeke M., Bauhofer A., Kopp I., and Koller M. Computerized visualization of quality of life data of individual cancer patients-the QoL-Profiler. Inflamm Res 53 Suppl 2 (2004) 175-178
7. Palese A., Lamanna F., Di-Monte C., et al. Quality of life in patients with right- or left-sided brain tumors: literature review. J Clin Nurs 17 11 (2008) 1403-1410
8. Salo J., Niemelä A., Joukamaa M., and Koivukangas J. Effect of brain tumor laterality on patient's perceived quality of life. J Neurol Neurosurg Psychiatry 72 (2002) 373-377
9. MacDonald D., Kiebert G., Padros M., Yung A., and Olson J. Benefit of temozolomide compared to procarbazine treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life. Cancer Invest 23 2 (2005) 138-144
10. Prados M., Schold S., Fine H., et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro Oncol 5 2 (2003) 96-103
11. Hart M., Grant R., Garside R., et al. Temozolomide for high grade glioma. Cochrane Database Syst Rev 4 (2008) CD007415
12. Holzner B., Zabernigg A., Kemmler G., et al. Computerized assessment of quality of life in patients undergoing chemotherapy. Qual Life Res 13 9 (2004) 1523
13. Holzner B, Giesinger J, Rumpold G, Weber B, Kemmler G. Computerized assessment of quality of life in daily clinical routine. EORTC Quality of Life Group Newsletter 2008;(7).
14. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 5 (1993) 365-376
15. Sprangers M.A., Cull A., Groenvold M., et al. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res 7 4 (1998) 291-300
16. Osoba D., Aaronson N.K., Muller M., et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5 1 (1996) 139-150
17. Fayers P.M. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 37 11 (2001) 1331-1334
18. Taphoorn M.J., Stupp R., Coens C., et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6 (2005) 937-944
19. Osoba D., Brada M., Prados M.D., and Yung W.K. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol 2 4 (2000) 221-228
20. Crosby R., Kolotkin R., and Williams G. An integrated method to determine meaningful changes in health-related quality of life. J Clin Epidemiol 57 11 (2004) 1153-1160
21. Kemmler G., Zabernigg A., Gattringer K., et al. A new approach to combining clinical relevance and statistical significance for evaluation of quality of life changes in the individual patient. J Clin Epidemiol (July 15 2009) [Epub ahead of print]
22. Young T., De Haes H., Curran D., et al. Guidelines for assessing quality of life in EORTC clinical trials (1999), EORTC, Brussels, Belgium
23. Scott N., Fayers P., Aaronson N., et al., Group obotEQoL. EORTC QLQ-C30 reference values (2008), EORTC Quality of Life Group, Brussels, Belgium
24. Velikova G., Booth L., Smith A.B., et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22 4 (2004) 714-724
25. Buxton J., White M., and Osoba D. Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res 7 6 (1998) 513-519
26. Taenzer P.A., Speca M., Atkinson M.J., et al. Computerized quality-of-life screening in an oncology clinic. Cancer Pract 5 3 (1997) 168-175
27. Carlson L.E., Speca M., Hagen N., and Taenzer P. Computerized quality-of-life screening in a cancer pain clinic. J Palliat Care 17 1 (2001) 46-52
28. Wright E.P., Selby P.J., Crawford M., et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21 2 (2003) 374-382
29. Cull A., Gould A., House A., et al. Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer 85 12 (2001) 1842-1849
30. Chang C.H., Cella D., Masters G.A., et al. Real-time clinical application of quality-of-life assessment in advanced lung cancer. Clin Lung Cancer 4 2 (2002) 104-109
31. Fortner B., Okon T., Schwartzberg L., Tauer K., and Houts A.C. The Cancer Care Monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage 26 6 (2003) 1077-1092
32. Fortner B., Baldwin S., Schwartzberg L., and Houts A.C. Validation of the Cancer Care Monitor items for physical symptoms and treatment side effects using expert oncology nurse evaluation. J Pain Symptom Manage 31 3 (2006) 207-214